{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:00:20Z","timestamp":1793070020465,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T00:00:00Z","timestamp":1714867200000},"content-version":"vor","delay-in-days":125,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Karolinska Institutet Foundations"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2021-01657 A.L.V.J."],"award-info":[{"award-number":["2021-01657 A.L.V.J."]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>What are the obstetric and perinatal outcomes in births to breast cancer survivors compared to women without previous breast cancer?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>Women who conceived during the first 2\u2009years following a breast cancer diagnosis had a higher risk for preterm birth, induced delivery, and cesarean section, while no increased risks were observed in births conceived later than 2\u2009years after a breast cancer diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>A recent meta-analysis found higher risks of cesarean section, preterm birth, low birthweight, and small for gestational age in pregnancies among breast cancer survivors. Less is known about rarer outcomes such as pre-eclampsia or congenital malformations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>We conducted a population-based matched cohort study including all breast cancer survivors who gave birth to singletons 1973\u20132017 in Sweden, identified through linkage between the Swedish Cancer Register, the Medical Birth Register, and the National Quality Register for Breast Cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTINGS, METHODS<\/jats:title>\n                    <jats:p>Each birth following breast cancer (n\u2009=\u2009926) was matched by maternal age at delivery, parity, and calendar year at delivery to 100 births in a comparator cohort of women (n\u2009=\u200992 490). Conditional logistic and multinomial regression models estimated relative risks (RR) with 95% CI. Subgroup analyses by time since diagnosis and type of treatment were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>Previous breast cancer was associated with higher risks of induced delivery (RR; 1.3, 1.0\u20131.6), very preterm birth (RR; 1.8, 1.1\u20133.0), and planned preterm birth (RR; 1.6, 1.0\u20132.4). Women who conceived within 1\u2009year after breast cancer diagnosis had higher risks of cesarean section (RR; 1.7, 1.0\u20132.7), very preterm birth (RR; 5.3, 1.9\u201314.8), and low birthweight (RR; 2.7, 1.4\u20135.2), while the risks of induced delivery (RR; 1.8, 1.1\u20132.9), moderately preterm birth (RR; 2.1, 1.2\u20133.7), and planned preterm birth (RR; 2.5, 1.1\u20135.7) were higher in women who conceived during the second year after diagnosis. Women who conceived later than 2\u2009years after breast cancer diagnosis had similar obstetric risks to their comparators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>As information on the end date of treatment was unavailable, the time between the date of diagnosis and conception was used as a proxy, which does not fully capture the effect of time since end of treatment. In addition, treatments and clinical recommendations have changed over the long study period, which may impact childbearing patterns in breast cancer survivors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>Risks of adverse obstetric outcomes in breast cancer survivors were confined to births conceived within 2\u2009years of diagnosis. As family building holds significance for numerous young breast cancer patients, these findings are particularly important to inform both breast cancer survivors and clinicians about future reproductive outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                    <jats:p>This work was supported by the Swedish Cancer Society (grant number 22-2044 Pj A.L.V.J.), Karolinska Institutet Foundations (grant number: 2022-01696 F.E.L., 2022-01559 A.L.V.J.), and the Swedish Research Council (grant number: 2021-01657 A.L.V.J.). K.A.R.-W. is supported by grants from the Swedish Cancer Society (20 0170 F) and the Radiumhemmets Research Foundations for clinical researchers 2020\u20132026. The authors declare that they have no conflicts of interest.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>N\/A.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/hropen\/hoae027","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T08:13:19Z","timestamp":1714637599000},"source":"Crossref","is-referenced-by-count":8,"title":["Obstetric and perinatal outcomes in women with previous breast cancer: a nationwide study of singleton births 1973\u20132017"],"prefix":"10.1093","volume":"2024","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3063-9960","authenticated-orcid":false,"given":"Leo","family":"Gkekos","sequence":"first","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1191-7231","authenticated-orcid":false,"given":"Anna L V","family":"Johansson","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm, Sweden"},{"name":"Cancer Registry of Norway, Norwegian Institute of Public Health , Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-6181","authenticated-orcid":false,"given":"Kenny A","family":"Rodriguez-Wallberg","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Laboratory of Translational Fertility Preservation, Karolinska Institutet , Stockholm, Sweden"},{"name":"Division of Gynecology and Reproduction, Department of Reproductive Medicine, Karolinska University Hospital , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7811-9317","authenticated-orcid":false,"given":"Irma","family":"Fredriksson","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm, Sweden"},{"name":"Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7061-7178","authenticated-orcid":false,"given":"Frida E","family":"Lundberg","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm, Sweden"},{"name":"Department of Oncology-Pathology, Laboratory of Translational Fertility Preservation, Karolinska Institutet , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,4]]},"reference":[{"key":"2024052304544017600_hoae027-B1","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s10815-021-02133-0","article-title":"Conception after chemotherapy: post-chemotherapy method of conception and pregnancy outcomes in breast cancer patients","volume":"38","author":"Abel","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"2024052304544017600_hoae027-B2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"key":"2024052304544017600_hoae027-B3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish Cancer Register\u2014a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"key":"2024052304544017600_hoae027-B4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13058-017-0803-z","article-title":"Prevalence of preterm, low birthweight, and small for gestational age delivery after breast cancer diagnosis: a population-based study","volume":"19","author":"Black","year":"2017","journal-title":"Breast Cancer Res"},{"key":"2024052304544017600_hoae027-B5","first-page":"3355","article-title":"The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer","volume":"48","author":"Cardoso","year":"2012","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"2024052304544017600_hoae027-B6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10654-022-00947-5","article-title":"The Swedish Medical Birth Register during five decades: documentation of the content and quality of the register","volume":"38","author":"Cnattingius","year":"2023","journal-title":"Eur J Epidemiol"},{"key":"2024052304544017600_hoae027-B7","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1158\/1078-0432.CCR-20-3974","article-title":"Early discontinuation of endocrine therapy and recurrence of breast cancer among premenopausal women","volume":"27","author":"Collin","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2024052304544017600_hoae027-B8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/14767058.2012.664943","article-title":"Congenital malformations","volume":"25","author":"Corsello","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2024052304544017600_hoae027-B9","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1371\/journal.pmed.0030336","article-title":"Birth outcome in women with previously treated breast cancer\u2014a population-based cohort study from Sweden","volume":"3","author":"Dalberg","year":"2006","journal-title":"PLoS Med"},{"key":"2024052304544017600_hoae027-B10","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(11)61351-2","article-title":"Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis","volume":"378","author":"Forouzanfar","year":"2011","journal-title":"Lancet"},{"key":"2024052304544017600_hoae027-B11","author":"Fredriksson","year":"2023"},{"key":"2024052304544017600_hoae027-B12","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1002\/cncr.31732","article-title":"Pregnancy after cancer: does timing of conception affect infant health?","volume":"124","author":"Hartnett","year":"2018","journal-title":"Cancer"},{"key":"2024052304544017600_hoae027-B13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10549-009-0724-3","article-title":"Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis","volume":"122","author":"Herk-Sukel","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"2024052304544017600_hoae027-B14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10549-018-4761-7","article-title":"Breast cancer survival, survival disparities, and guideline-based treatment","volume":"170","author":"Hill","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"2024052304544017600_hoae027-B15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00432-017-2352-3","article-title":"Impact of prior breast cancer on mode of delivery and pregnancy-associated disorders: a retrospective analysis of subsequent pregnancy outcomes","volume":"143","author":"Jacob","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"2024052304544017600_hoae027-B16","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1200\/JCO.21.00535","article-title":"Pregnancy after breast cancer: a systematic review and meta-analysis","volume":"39","author":"Lambertini","year":"2021","journal-title":"J Clin Oncol"},{"key":"2024052304544017600_hoae027-B17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/sj.bjc.6602878","article-title":"Birth outcome in women with breast cancer","volume":"94","author":"Langagergaard","year":"2006","journal-title":"Br J Cancer"},{"key":"2024052304544017600_hoae027-B18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10549-019-05244-6","article-title":"Childbirth in young Korean women with previously treated breast cancer: The SMARTSHIP study","volume":"176","author":"Lee","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"2024052304544017600_hoae027-B19","doi-asserted-by":"crossref","first-page":"12464","DOI":"10.1038\/s41598-021-92032-2","article-title":"Swedish intrauterine growth reference ranges for estimated fetal weight","volume":"11","author":"Lindstr\u00f6m","year":"2021","journal-title":"Sci Rep"},{"key":"2024052304544017600_hoae027-B20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s12889-019-6846-6","article-title":"Validation of data quality in the Swedish National Register for Breast Cancer","volume":"19","author":"L\u00f6fgren","year":"2019","journal-title":"BMC Public Health"},{"key":"2024052304544017600_hoae027-B21","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa2212856","article-title":"Interrupting endocrine therapy to attempt pregnancy after breast cancer","volume":"388","author":"Partridge","year":"2023","journal-title":"N Engl J Med"},{"key":"2024052304544017600_hoae027-B22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00404-016-4250-3","article-title":"Worldwide prevalence of adverse pregnancy outcomes among singleton pregnancies after in vitro fertilization\/intracytoplasmic sperm injection: a systematic review and meta-analysis","volume":"295","author":"Qin","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"2024052304544017600_hoae027-B23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.5603\/GP.2016.0062","article-title":"Breast cancer in young women","volume":"87","author":"Radecka","year":"2016","journal-title":"Ginekol Pol"},{"key":"2024052304544017600_hoae027-B24","author":"Regionala cancercentrum i samverkan","year":"2023"},{"key":"2024052304544017600_hoae027-B25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-014-2891-0","article-title":"Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103","volume":"144","author":"Ruddy","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"2024052304544017600_hoae027-B26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.breast.2019.07.001","article-title":"Fertility concerns, preservation strategies and quality of life in young women with breast cancer: baseline results from an ongoing prospective cohort study in selected European Centers","volume":"47","author":"Ruggeri","year":"2019","journal-title":"Breast"},{"key":"2024052304544017600_hoae027-B27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-0038-1668117","article-title":"Multiple pregnancy: epidemiology and association with maternal and perinatal morbidity","volume":"40","author":"Santana","year":"2018","journal-title":"Rev Bras Ginecol Obstet"},{"key":"2024052304544017600_hoae027-B28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.hoc.2013.05.005","article-title":"Breast cancer survivorship issues","volume":"27","author":"Stan","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"2024052304544017600_hoae027-B29","first-page":"2696","article-title":"Birth outcomes among offspring of adult cancer survivors: a population-based study","volume":"133","author":"Stensheim","year":"2013","journal-title":"Int J Cancer"},{"key":"2024052304544017600_hoae027-B30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13058-015-0669-x","article-title":"Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer","volume":"18","author":"Verma","year":"2016","journal-title":"Breast Cancer Res"},{"key":"2024052304544017600_hoae027-B31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"2024052304544017600_hoae027-B32","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.25037","article-title":"Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy","volume":"116","author":"Yu","year":"2010","journal-title":"Cancer"}],"container-title":["Human Reproduction Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/hropen\/advance-article-pdf\/doi\/10.1093\/hropen\/hoae027\/57405494\/hoae027.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hropen\/article-pdf\/2024\/2\/hoae027\/57830463\/hoae027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hropen\/article-pdf\/2024\/2\/hoae027\/57830463\/hoae027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T03:00:01Z","timestamp":1716433201000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hropen\/article\/doi\/10.1093\/hropen\/hoae027\/7665152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/hropen\/hoae027","relation":{},"ISSN":["2399-3529"],"issn-type":[{"value":"2399-3529","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2024,1,1]]},"article-number":"hoae027"}}